KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Payables: 2018-2025

Historic Payables for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $11.1 million.

  • Twist Bioscience's Payables rose 580.61% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.6 million, marking a year-over-year increase of 53.26%. This contributed to the annual value of $11.1 million for FY2025, which is 580.61% up from last year.
  • Twist Bioscience's Payables amounted to $11.1 million in Q3 2025, which was down 7.43% from $12.0 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's Payables ranged from a high of $23.1 million in Q4 2021 and a low of $1.6 million during Q3 2024.
  • In the last 3 years, Twist Bioscience's Payables had a median value of $8.7 million in 2023 and averaged $8.9 million.
  • Its Payables has fluctuated over the past 5 years, first slumped by 53.98% in 2023, then soared by 580.61% in 2025.
  • Quarterly analysis of 5 years shows Twist Bioscience's Payables stood at $23.1 million in 2021, then dropped by 12.83% to $20.1 million in 2022, then plummeted by 53.98% to $9.3 million in 2023, then declined by 18.94% to $7.5 million in 2024, then skyrocketed by 580.61% to $11.1 million in 2025.
  • Its Payables stands at $11.1 million for Q3 2025, versus $12.0 million for Q2 2025 and $8.1 million for Q1 2025.